ResearcherKawasaki Medical SchoolNo recent work listed
Masahiro Yamamura
Known by name at one institution; no external author ID yet. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 1, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 13
2016: 1 paper · 2017: 1 paper · 2018: none · 2019: 1 paper · 2020: none · 2021: none · 2022: 2 papers
Papers 5
- Inhibition of pancreatic cancer-cell growth and metastasis in vivo by a pyrazole compound characterized as a cell-migration inhibitor by an in vitro chemotaxis… Co-author DOI 10.1016/j.biopha.2022.113733↗
- Republication: A Prospective Observational Study of Adoptive Immunotherapy for Cancer Using Zoledronate-Activated Killer (ZAK) Cells - An Analysis for Patients… Last author DOI 10.21873/anticanres.15584↗
- Upregulation of Mobility in Pancreatic Cancer Cells by Secreted S100A11 Through Activation of Surrounding Fibroblasts. Co-author DOI 10.3727/096504019x15555408784978↗
- Evaluation of pancreatic cancer cell migration with multiple parameters in vitro by using an optical real-time cell mobility assay device. First author DOI 10.1186/s12885-017-3218-4↗
- A Prospective Observational Study of Adoptive Immunotherapy for Cancer Using Zoledronate-Activated Killer (ZAK) Cells - An Analysis for Patients with Incurable… Last author PMID 27127137↗
Closest collaborators
The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Yoshiyuki Yamaguchi · 3 shared papers, 2016–2022 · strength 0.35
- Paper Republication: A Prospective Observational Study of Adoptive Immunotherapy for Cancer Using Zoledronate-Activated Kille… DOI 10.21873/anticanres.15584↗
- Paper A Prospective Observational Study of Adoptive Immunotherapy for Cancer Using Zoledronate-Activated Killer (ZAK) Cells -… PMID 27127137↗
- Paper Evaluation of pancreatic cancer cell migration with multiple parameters in vitro by using an optical real-time cell mob… DOI 10.1186/s12885-017-3218-4↗
- 明 山内 · 3 shared papers, 2017–2022 · strength 0.25
- Paper Inhibition of pancreatic cancer-cell growth and metastasis in vivo by a pyrazole compound characterized as a cell-migra… DOI 10.1016/j.biopha.2022.113733↗
- Paper Evaluation of pancreatic cancer cell migration with multiple parameters in vitro by using an optical real-time cell mob… DOI 10.1186/s12885-017-3218-4↗
- Paper Upregulation of Mobility in Pancreatic Cancer Cells by Secreted S100A11 Through Activation of Surrounding Fibroblasts. DOI 10.3727/096504019x15555408784978↗
- Futoshi Kuribayashi · 2 shared papers, 2017–2022 · strength 0.18
- Paper Inhibition of pancreatic cancer-cell growth and metastasis in vivo by a pyrazole compound characterized as a cell-migra… DOI 10.1016/j.biopha.2022.113733↗
- Paper Evaluation of pancreatic cancer cell migration with multiple parameters in vitro by using an optical real-time cell mob… DOI 10.1186/s12885-017-3218-4↗
- Masakiyo Sakaguchi · 2 shared papers, 2019–2022 · strength 0.18
- Paper Inhibition of pancreatic cancer-cell growth and metastasis in vivo by a pyrazole compound characterized as a cell-migra… DOI 10.1016/j.biopha.2022.113733↗
- Paper Upregulation of Mobility in Pancreatic Cancer Cells by Secreted S100A11 Through Activation of Surrounding Fibroblasts. DOI 10.3727/096504019x15555408784978↗
- Tomio Ueno · 1 shared paper, 2022 · strength 0.11
- Shuichiro Okamoto · 1 shared paper, 2022 · strength 0.11
- Keisuke Hino · 1 shared paper, 2022 · strength 0.11
- Norihiko Sugisawa · 1 shared paper, 2022 · strength 0.11
- Robert M. Hoffman · 1 shared paper, 2022 · strength 0.11
- Masafumi Nakamura · 1 shared paper, 2017 · strength 0.07
- Ken Saito · 1 shared paper, 2019 · strength 0.07
- Eisaku Kondo · 1 shared paper, 2019 · strength 0.07
- Yosuke Mitsui · 1 shared paper, 2019 · strength 0.07
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.